跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70 mg/ colecalciferol 140ug tablets and 1250mg calcium carbonate tablets composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70 mg/ colecalciferol 140ug tablets and 1250mg calcium carbonate tablets composite pack
Approved
STANDARD
Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70 mg/ colecalciferol 140ug tablets and 1250mg calcium carbonate tablets composite pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b037ed0d6b78e9d2
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
b037ed0d6b78e9d2
Product Name
Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70 mg/ colecalciferol 140ug tablets and 1250mg calcium carbonate tablets composite pack
Artg Id
246775
Artg Name
Alendronate Plus D3 and calcium APOTEX alendronic acid (as sodium) 70mg/ colecalciferol 140ug tablets and calcium 500mg tablets composite pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2016-05-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b037ed0d6b78e9d2
Type
Standard
Back to TGA Approvals